Key result
Extracorporeal life support using Impella CP for eight days led to recovery and normal cardiac function at six months in a patient with fulminant myocarditis and cardiogenic shock.
Population
49-year-old female presenting with fulminant myocarditis, cardiogenic shock, and subsequent cardiac arrest
Design
Case_report
Follow-up
6 months
Authors
Loading...
May support Impella CP in fulminant myocarditis shock; hypothesis-generating and requires prospective trials before practice change.
Case Report (n=1)
Extracorporeal life support with Impella CP can be a life-saving and reversible treatment strategy for fulminant myocarditis complicated by cardiogenic shock.
Fox et al. (2017) conducted a case report in Fulminant myocarditis (n=1). Extracorporeal life support (Impella CP) was evaluated on Recovery of cardiac function. Extracorporeal life support using Impella CP for eight days led to recovery and normal cardiac function at six months in a patient with fulminant myocarditis and cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: